The antitumor function of Herceptin includes activating the PI3K inhibitor PTEN, which leads to rapid Akt dephosphorylation and inhibition of cell proliferation, and inducing an ADCC response, which involves an increment in the infiltration of NK cells and subsequent NK cell-mediated tumor cell lysis 17. The gene discussed is AKT1; the disease is neoplasm.